Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-08-18
1981-11-17
Cacciapaglia, Jr., Frank
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3120
Patent
active
043011764
ABSTRACT:
A chewable anticonvulsant tablet dosage form consisting essentially of calcium valproate and a pharmaceutically acceptable carrier is disclosed. This novel dosage form is conveniently administered and is not irritating to the mucosa of the mouth and throat.
REFERENCES:
patent: 3301754 (1967-01-01), Meunier
patent: 3325361 (1967-06-01), Meunier
patent: 3814812 (1974-06-01), Eymard
patent: 4025649 (1977-05-01), Taillandier et al.
Lachman et al. "Theory and Practice of Industrial Pharmacy", 2nd Ed., 1976 (Lea & Febiger, Phil.) pp. 339-340.
Grabowski Albert T.
Khan Sadath U.
Cacciapaglia, Jr. Frank
Miller Stephen I.
Warner-Lambert & Company
LandOfFree
Method of administering calcium valproate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of administering calcium valproate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of administering calcium valproate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1292460